Literature DB >> 11665959

Atherosclerosis and lupus: a work in progress.

M D Lockshin, J E Salmon, M J Roman.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11665959     DOI： 10.1002/1529-0131(200110)44:10<2215::aid-art381>3.0.co;2-o

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  13 in total

Review 1.  The role of invariant natural killer T cells in lupus and atherogenesis.

Authors:  Amy S Major; Ram R Singh; Sebastian Joyce; Luc Van Kaer
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 2.  Cardiac involvement in systemic autoimmune diseases.

Authors:  Piersandro Riboldi; Maria Gerosa; Cristina Luzzana; Luca Catelli
Journal:  Clin Rev Allergy Immunol       Date:  2002-12       Impact factor: 8.667

3.  Osteoporosis and cardiovascular disease care in systemic lupus erythematosus according to new quality indicators.

Authors:  Kristina L Demas; Brendan T Keenan; Daniel H Solomon; Jinoos Yazdany; Karen H Costenbader
Journal:  Semin Arthritis Rheum       Date:  2010-04-08       Impact factor: 5.532

4.  Simvastatin treatment ameliorates autoimmune disease associated with accelerated atherosclerosis in a murine lupus model.

Authors:  Tamar Aprahamian; Ramon Bonegio; Jennifer Rizzo; Harris Perlman; David J Lefer; Ian R Rifkin; Kenneth Walsh
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

5.  Resveratrol counters systemic lupus erythematosus-associated atherogenicity by normalizing cholesterol efflux.

Authors:  Iryna Voloshyna; Isaac Teboul; Michael J Littlefield; Nicolle M Siegart; George K Turi; Melissa J Fazzari; Steven E Carsons; Joshua DeLeon; Allison B Reiss
Journal:  Exp Biol Med (Maywood)       Date:  2016-04-27

Review 6.  Effects of inflammation on cholesterol metabolism: impact on systemic lupus erythematosus.

Authors:  Allison B Reiss
Journal:  Curr Rheumatol Rep       Date:  2009-08       Impact factor: 4.592

7.  Accelerated atherosclerosis is independent of feeding high fat diet in systemic lupus erythematosus-susceptible LDLr(-/-) mice.

Authors:  N a Braun; N S Wade; E K Wakeland; A S Major
Journal:  Lupus       Date:  2008-12       Impact factor: 2.911

8.  Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus.

Authors:  A Doria; Y Shoenfeld; R Wu; P F Gambari; M Puato; A Ghirardello; B Gilburd; S Corbanese; M Patnaik; S Zampieri; J B Peter; E Favaretto; L Iaccarino; Y Sherer; S Todesco; P Pauletto
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

9.  Prevalence and associations of an abnormal ankle-brachial index in systemic lupus erythematosus: a pilot study.

Authors:  A Theodoridou; L Bento; D P D'Cruz; M A Khamashta; G R V Hughes
Journal:  Ann Rheum Dis       Date:  2003-12       Impact factor: 19.103

10.  The effect of mycophenolate mofetil on disease development in the gld.apoE (-/-) mouse model of accelerated atherosclerosis and systemic lupus erythematosus.

Authors:  Christophe Richez; Rocco J Richards; Pierre Duffau; Zachary Weitzner; Christopher D Andry; Ian R Rifkin; Tamar Aprahamian
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.